- 2013
- Press releases - 07.06.2013
Optogenetics is proving to be highly promising in the treatment of obsessive-compulsive disorders
Thanks to work carried out by the Massachusetts Institute of Technology in Boston, Eric Burguière, an Inserm researcher working in the MHI research centre and his co-workers have succeeded in reducing the compulsive behaviour of mice using optogenetics, a technique that combines light stimulation with genetic engineering.
- What's on? - 03.06.2013
Diabetes Awareness Week
Diabetes awareness week takes place from June 3rd to 9th in France. Have the opportunity to talk with our specialists. What’s on with researches? For more information: Pascal FERRE, Inserm research director at the Inserm Unit called « Nutritional and Metabolic Pathologies: obesity and diabetes”, at the Centre des Cordeliers. François Pattou, Inserm Unit 859 «Diabetes […]
- Press releases - 28.05.2013
Physicians insufficiently informed of the side effects of drugs.
The physicians are not given enough information about the adverse effects of drugs during presentations made by medical sales representatives from pharmaceutical companies. And yet, these same physicians are willing to prescribe at least some of the presented drugs. Dr. Geneviève Durrieu (from the Pharmaco-epidemiology team assessing the use of medication and the risks involved, Unit 1027 “Epidemiology and public health analyses: risks, chronic diseases and handicaps” – Inserm / Université Toulouse III – Paul Sabatier) led the French part of this study, the results of which are published in the Journal of General Internal Medicine. Within the framework of this international study, is France proving to be a model student?
- What's on? - 28.05.2013
Impact of Tobacco on Mortality
Tobacco kills almost six million people worldwide, whether they are active or passive smokers, and this represents 6% of the world population of women and 12% of the population of men. The association between tobacco and the risk of a specific cancer on the one hand and the global cancer risk on the other hand […]
- Press releases - 27.05.2013
The Health and Care of Pregnant Women and Babies in Europe in 2010
The burden of mortality and morbidity in the perinatal period – pregnancy, childbirth, and the postpartum – remains a major concern in Europe. Over 5 million women deliver babies in European countries every year.
- Press releases - 23.05.2013
Analysis of metabolic fingerprints of pregnant women living in proximity to cereal farming areas
An exploratory study published today by Sylvaine Cordier and her team and researchers from Inra in Toulouse, suggests that environmental exposure to complex pesticide mixtures could led to metabolic disturbance in pregnant women.
- News in brief - 23.05.2013
A major advance in colon cancer
A French consortium of clinicians and biologists has proposed a molecular classification of colon cancers into six sub-types. A national multicentric consortium of clinicians, biologists and researchers performed a genomic study as part of the CIT programme (Cartes d’Identité des Tumeurs® [Tumour Identity Cards]) of the Ligue contre le Cancer. The study included tumours from […]
- Press releases - 22.05.2013
The “Young Researchers” congress to be held in 5 towns in France, on the theme of addiction
Over the whole school year, 20 middle school and high school pupils were seen each month in 5 neuroscience laboratories specializing in the study of addictions.
- What's on? - 21.05.2013
Does time affect our mental health?
Bad weather and rain are at the heart of all discussions. After a long, cold winter and a virtually non-existent start to spring, grey skies predominate in France. Do these temperature variations impact our mood? Is it known whether the weather affects our mental health? What are the effects of light on our health and on human […]
- Press releases - 16.05.2013
Vesicular transport: a requirement for T immune response
Claire Hivroz, INSERM Research Director and her colleagues recently showed in an article published in Nature immunology how a specific protein known as VAMP7 is essential for transporting the signal produced by the ligand–TCR link.